nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—CYP2B6—Thiotepa—urinary bladder cancer	0.251	0.3	CbGbCtD
Epinastine—ABCB1—Mitomycin—urinary bladder cancer	0.17	0.203	CbGbCtD
Epinastine—CYP3A4—Thiotepa—urinary bladder cancer	0.0771	0.0921	CbGbCtD
Epinastine—CYP2B6—Cisplatin—urinary bladder cancer	0.0692	0.0827	CbGbCtD
Epinastine—ABCB1—Gemcitabine—urinary bladder cancer	0.0488	0.0584	CbGbCtD
Epinastine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0464	0.0554	CbGbCtD
Epinastine—HTR7—vas deferens—urinary bladder cancer	0.0389	0.322	CbGeAlD
Epinastine—ABCB1—Cisplatin—urinary bladder cancer	0.0355	0.0424	CbGbCtD
Epinastine—ABCB1—Etoposide—urinary bladder cancer	0.0349	0.0417	CbGbCtD
Epinastine—ABCB1—Doxorubicin—urinary bladder cancer	0.0238	0.0284	CbGbCtD
Epinastine—ABCB1—Methotrexate—urinary bladder cancer	0.023	0.0275	CbGbCtD
Epinastine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0224	0.0268	CbGbCtD
Epinastine—CYP3A4—Etoposide—urinary bladder cancer	0.0209	0.025	CbGbCtD
Epinastine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0142	0.017	CbGbCtD
Epinastine—HTR2A—urine—urinary bladder cancer	0.00604	0.0499	CbGeAlD
Epinastine—CYP3A4—urine—urinary bladder cancer	0.00559	0.0462	CbGeAlD
Epinastine—CYP2D6—urine—urinary bladder cancer	0.0055	0.0455	CbGeAlD
Epinastine—ADRA1A—prostate gland—urinary bladder cancer	0.00335	0.0277	CbGeAlD
Epinastine—HRH1—prostate gland—urinary bladder cancer	0.0026	0.0215	CbGeAlD
Epinastine—HTR7—epithelium—urinary bladder cancer	0.00255	0.0211	CbGeAlD
Epinastine—ADRA2A—prostate gland—urinary bladder cancer	0.00255	0.0211	CbGeAlD
Epinastine—ADRA1A—epithelium—urinary bladder cancer	0.00246	0.0204	CbGeAlD
Epinastine—HTR7—smooth muscle tissue—urinary bladder cancer	0.00246	0.0204	CbGeAlD
Epinastine—HTR7—renal system—urinary bladder cancer	0.00237	0.0196	CbGeAlD
Epinastine—ADRA1A—renal system—urinary bladder cancer	0.00229	0.0189	CbGeAlD
Epinastine—Carbamazepine—UGT2B7—urinary bladder cancer	0.00228	1	CrCbGaD
Epinastine—HRH2—lymph node—urinary bladder cancer	0.00218	0.0181	CbGeAlD
Epinastine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00216	0.0178	CbGeAlD
Epinastine—HRH1—epithelium—urinary bladder cancer	0.00191	0.0158	CbGeAlD
Epinastine—HTR7—female reproductive system—urinary bladder cancer	0.0019	0.0157	CbGeAlD
Epinastine—HRH1—smooth muscle tissue—urinary bladder cancer	0.00184	0.0152	CbGeAlD
Epinastine—CYP2B6—renal system—urinary bladder cancer	0.00181	0.015	CbGeAlD
Epinastine—HRH1—urethra—urinary bladder cancer	0.00174	0.0144	CbGeAlD
Epinastine—ADRA2A—urethra—urinary bladder cancer	0.00171	0.0141	CbGeAlD
Epinastine—HTR2A—epithelium—urinary bladder cancer	0.00159	0.0132	CbGeAlD
Epinastine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00153	0.0127	CbGeAlD
Epinastine—HTR2A—renal system—urinary bladder cancer	0.00148	0.0122	CbGeAlD
Epinastine—CYP2B6—female reproductive system—urinary bladder cancer	0.00145	0.012	CbGeAlD
Epinastine—ABCB1—prostate gland—urinary bladder cancer	0.00142	0.0117	CbGeAlD
Epinastine—HRH1—female reproductive system—urinary bladder cancer	0.00142	0.0117	CbGeAlD
Epinastine—ADRA2A—female reproductive system—urinary bladder cancer	0.00139	0.0115	CbGeAlD
Epinastine—CYP3A4—renal system—urinary bladder cancer	0.00137	0.0113	CbGeAlD
Epinastine—CYP2D6—renal system—urinary bladder cancer	0.00135	0.0111	CbGeAlD
Epinastine—CYP2B6—vagina—urinary bladder cancer	0.00131	0.0108	CbGeAlD
Epinastine—HRH1—vagina—urinary bladder cancer	0.00128	0.0106	CbGeAlD
Epinastine—ADRA2A—vagina—urinary bladder cancer	0.00126	0.0104	CbGeAlD
Epinastine—ABCB1—seminal vesicle—urinary bladder cancer	0.0012	0.00993	CbGeAlD
Epinastine—HTR2A—female reproductive system—urinary bladder cancer	0.00118	0.00978	CbGeAlD
Epinastine—CYP3A4—female reproductive system—urinary bladder cancer	0.0011	0.00906	CbGeAlD
Epinastine—CYP2D6—female reproductive system—urinary bladder cancer	0.00108	0.00891	CbGeAlD
Epinastine—HTR2A—vagina—urinary bladder cancer	0.00107	0.00885	CbGeAlD
Epinastine—ABCB1—epithelium—urinary bladder cancer	0.00104	0.00863	CbGeAlD
Epinastine—ABCB1—renal system—urinary bladder cancer	0.000968	0.00801	CbGeAlD
Epinastine—ABCB1—urethra—urinary bladder cancer	0.000951	0.00786	CbGeAlD
Epinastine—HRH1—lymph node—urinary bladder cancer	0.000829	0.00685	CbGeAlD
Epinastine—ADRA2A—lymph node—urinary bladder cancer	0.000814	0.00673	CbGeAlD
Epinastine—ABCB1—female reproductive system—urinary bladder cancer	0.000775	0.00641	CbGeAlD
Epinastine—ABCB1—vagina—urinary bladder cancer	0.000701	0.0058	CbGeAlD
Epinastine—ABCB1—lymph node—urinary bladder cancer	0.000454	0.00375	CbGeAlD
Epinastine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.72e-05	0.000429	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.7e-05	0.000424	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TSC1—urinary bladder cancer	1.69e-05	0.000423	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—KRAS—urinary bladder cancer	1.68e-05	0.00042	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.68e-05	0.000418	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—RHOA—urinary bladder cancer	1.64e-05	0.000409	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—FGFR3—urinary bladder cancer	1.63e-05	0.000407	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—EP300—urinary bladder cancer	1.62e-05	0.000405	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—JAG1—urinary bladder cancer	1.61e-05	0.000403	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.6e-05	0.000399	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—ESR1—urinary bladder cancer	1.58e-05	0.000395	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—SRC—urinary bladder cancer	1.58e-05	0.000394	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.57e-05	0.000392	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.57e-05	0.000392	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—GSTP1—urinary bladder cancer	1.53e-05	0.000381	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.52e-05	0.000381	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—ERBB2—urinary bladder cancer	1.52e-05	0.000379	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—RHOA—urinary bladder cancer	1.5e-05	0.000374	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—RHOA—urinary bladder cancer	1.49e-05	0.000373	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.48e-05	0.00037	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.48e-05	0.00037	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—RHOA—urinary bladder cancer	1.47e-05	0.000366	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CXCL8—urinary bladder cancer	1.44e-05	0.000359	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.44e-05	0.000359	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—S100B—urinary bladder cancer	1.44e-05	0.000358	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.43e-05	0.000358	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—S100B—urinary bladder cancer	1.43e-05	0.000358	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—HRAS—urinary bladder cancer	1.43e-05	0.000357	CbGpPWpGaD
Epinastine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.43e-05	0.000356	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—TYMS—urinary bladder cancer	1.42e-05	0.000355	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—S100B—urinary bladder cancer	1.41e-05	0.000351	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—GSTM1—urinary bladder cancer	1.4e-05	0.000351	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—NCOR1—urinary bladder cancer	1.4e-05	0.000351	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CREBBP—urinary bladder cancer	1.39e-05	0.000346	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL2—urinary bladder cancer	1.37e-05	0.000343	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IGF1—urinary bladder cancer	1.37e-05	0.000342	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—EGFR—urinary bladder cancer	1.36e-05	0.00034	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—RHOA—urinary bladder cancer	1.36e-05	0.00034	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—RHOA—urinary bladder cancer	1.36e-05	0.00034	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—RHOA—urinary bladder cancer	1.36e-05	0.000339	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—GPX1—urinary bladder cancer	1.34e-05	0.000336	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CCND1—urinary bladder cancer	1.34e-05	0.000335	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.34e-05	0.000334	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—RHOA—urinary bladder cancer	1.33e-05	0.000333	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.33e-05	0.000332	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ERCC2—urinary bladder cancer	1.32e-05	0.00033	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.32e-05	0.000329	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.32e-05	0.000329	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.32e-05	0.000328	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.31e-05	0.000328	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—KRAS—urinary bladder cancer	1.31e-05	0.000326	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—S100B—urinary bladder cancer	1.31e-05	0.000326	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MMP9—urinary bladder cancer	1.3e-05	0.000325	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.3e-05	0.000324	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—PTEN—urinary bladder cancer	1.29e-05	0.000323	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NCOR1—urinary bladder cancer	1.29e-05	0.000322	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—KRAS—urinary bladder cancer	1.29e-05	0.000322	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.29e-05	0.000322	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NCOR1—urinary bladder cancer	1.29e-05	0.000321	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.27e-05	0.000316	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NCOR1—urinary bladder cancer	1.26e-05	0.000315	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.26e-05	0.000315	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—IL2—urinary bladder cancer	1.26e-05	0.000314	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—RHOA—urinary bladder cancer	1.26e-05	0.000313	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—IL2—urinary bladder cancer	1.25e-05	0.000313	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—MTHFR—urinary bladder cancer	1.24e-05	0.00031	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—RHOA—urinary bladder cancer	1.24e-05	0.000309	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.24e-05	0.000309	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—EP300—urinary bladder cancer	1.23e-05	0.000308	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—IL2—urinary bladder cancer	1.23e-05	0.000307	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.21e-05	0.000302	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—SRC—urinary bladder cancer	1.2e-05	0.000299	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.2e-05	0.000299	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CXCL8—urinary bladder cancer	1.19e-05	0.000298	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.19e-05	0.000298	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.19e-05	0.000298	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NCOR1—urinary bladder cancer	1.17e-05	0.000293	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CXCL8—urinary bladder cancer	1.17e-05	0.000292	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.16e-05	0.00029	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—ERBB2—urinary bladder cancer	1.16e-05	0.00029	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—TP53—urinary bladder cancer	1.16e-05	0.00029	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—IL2—urinary bladder cancer	1.14e-05	0.000285	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL2—urinary bladder cancer	1.14e-05	0.000285	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL2—urinary bladder cancer	1.14e-05	0.000284	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TERT—urinary bladder cancer	1.14e-05	0.000284	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TERT—urinary bladder cancer	1.13e-05	0.000283	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL2—urinary bladder cancer	1.12e-05	0.000279	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TERT—urinary bladder cancer	1.11e-05	0.000278	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—HRAS—urinary bladder cancer	1.11e-05	0.000277	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CXCL8—urinary bladder cancer	1.1e-05	0.000275	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—HRAS—urinary bladder cancer	1.09e-05	0.000273	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CXCL8—urinary bladder cancer	1.09e-05	0.000271	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MYC—urinary bladder cancer	1.07e-05	0.000268	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.06e-05	0.000264	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL2—urinary bladder cancer	1.05e-05	0.000263	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—EGFR—urinary bladder cancer	1.05e-05	0.000262	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.05e-05	0.000261	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—FGFR3—urinary bladder cancer	1.04e-05	0.000261	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—FGFR3—urinary bladder cancer	1.04e-05	0.00026	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL2—urinary bladder cancer	1.04e-05	0.000259	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TERT—urinary bladder cancer	1.03e-05	0.000258	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCND1—urinary bladder cancer	1.03e-05	0.000256	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—FGFR3—urinary bladder cancer	1.02e-05	0.000255	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—ESR1—urinary bladder cancer	1.01e-05	0.000253	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—ESR1—urinary bladder cancer	1.01e-05	0.000253	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PPARG—urinary bladder cancer	1.01e-05	0.000251	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MMP9—urinary bladder cancer	9.97e-06	0.000249	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	9.96e-06	0.000249	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—KRAS—urinary bladder cancer	9.93e-06	0.000248	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CDKN1A—urinary bladder cancer	9.93e-06	0.000248	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—ESR1—urinary bladder cancer	9.92e-06	0.000248	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—PTEN—urinary bladder cancer	9.91e-06	0.000247	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—TYMS—urinary bladder cancer	9.82e-06	0.000245	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	9.71e-06	0.000242	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	9.71e-06	0.000242	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	9.68e-06	0.000242	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	9.68e-06	0.000242	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—CREBBP—urinary bladder cancer	9.67e-06	0.000241	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—FGFR3—urinary bladder cancer	9.49e-06	0.000237	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EP300—urinary bladder cancer	9.45e-06	0.000236	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	9.43e-06	0.000236	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.39e-06	0.000234	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.3e-06	0.000232	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	9.25e-06	0.000231	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—ESR1—urinary bladder cancer	9.22e-06	0.00023	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—SRC—urinary bladder cancer	9.19e-06	0.000229	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	9.15e-06	0.000228	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	9.15e-06	0.000228	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.13e-06	0.000228	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	9.06e-06	0.000226	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CREBBP—urinary bladder cancer	8.88e-06	0.000222	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	8.86e-06	0.000221	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TP53—urinary bladder cancer	8.83e-06	0.00022	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IGF1—urinary bladder cancer	8.77e-06	0.000219	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	8.76e-06	0.000219	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	8.75e-06	0.000219	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—EGFR—urinary bladder cancer	8.73e-06	0.000218	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	8.71e-06	0.000217	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CREBBP—urinary bladder cancer	8.7e-06	0.000217	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	8.6e-06	0.000215	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IGF1—urinary bladder cancer	8.59e-06	0.000214	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.58e-06	0.000214	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—EGFR—urinary bladder cancer	8.55e-06	0.000213	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—HRAS—urinary bladder cancer	8.44e-06	0.000211	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—KRAS—urinary bladder cancer	8.25e-06	0.000206	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MYC—urinary bladder cancer	8.23e-06	0.000206	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	8.23e-06	0.000205	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	8.08e-06	0.000202	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CREBBP—urinary bladder cancer	8.08e-06	0.000202	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—KRAS—urinary bladder cancer	8.07e-06	0.000202	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EGFR—urinary bladder cancer	8.05e-06	0.000201	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—RHOA—urinary bladder cancer	8.04e-06	0.000201	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	8.02e-06	0.0002	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IGF1—urinary bladder cancer	7.98e-06	0.000199	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—EGFR—urinary bladder cancer	7.94e-06	0.000198	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTGS2—urinary bladder cancer	7.91e-06	0.000198	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	7.87e-06	0.000196	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.8e-06	0.000195	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—KRAS—urinary bladder cancer	7.61e-06	0.00019	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	7.5e-06	0.000187	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	7.44e-06	0.000186	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	7.42e-06	0.000185	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	7.42e-06	0.000185	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	7.31e-06	0.000183	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	7.28e-06	0.000182	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	7.05e-06	0.000176	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	7.04e-06	0.000176	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	7.01e-06	0.000175	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	6.99e-06	0.000175	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPARG—urinary bladder cancer	6.96e-06	0.000174	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	6.91e-06	0.000172	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTEN—urinary bladder cancer	6.9e-06	0.000172	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	6.86e-06	0.000171	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	6.77e-06	0.000169	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TP53—urinary bladder cancer	6.76e-06	0.000169	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	6.74e-06	0.000168	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	6.73e-06	0.000168	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.68e-06	0.000167	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	6.6e-06	0.000165	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—EP300—urinary bladder cancer	6.58e-06	0.000164	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	6.57e-06	0.000164	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	6.56e-06	0.000164	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	6.56e-06	0.000164	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.51e-06	0.000163	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	6.47e-06	0.000162	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—HRAS—urinary bladder cancer	6.47e-06	0.000161	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	6.44e-06	0.000161	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	6.42e-06	0.00016	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	6.38e-06	0.000159	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	6.38e-06	0.000159	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	6.37e-06	0.000159	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.36e-06	0.000159	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.34e-06	0.000158	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	6.34e-06	0.000158	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	6.33e-06	0.000158	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	6.3e-06	0.000157	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	6.25e-06	0.000156	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.23e-06	0.000155	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	6.21e-06	0.000155	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—EP300—urinary bladder cancer	6.17e-06	0.000154	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	6.13e-06	0.000153	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.05e-06	0.000151	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	6.05e-06	0.000151	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	6.04e-06	0.000151	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.98e-06	0.000149	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.98e-06	0.000149	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	5.98e-06	0.000149	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	5.92e-06	0.000148	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	5.88e-06	0.000147	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	5.87e-06	0.000147	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	5.81e-06	0.000145	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	5.78e-06	0.000144	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	5.77e-06	0.000144	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	5.76e-06	0.000144	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.73e-06	0.000143	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.62e-06	0.00014	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	5.5e-06	0.000137	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.47e-06	0.000137	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	5.35e-06	0.000134	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.29e-06	0.000132	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	5.27e-06	0.000132	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	5.26e-06	0.000131	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	5.16e-06	0.000129	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	5.16e-06	0.000129	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	5.16e-06	0.000129	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	5.15e-06	0.000128	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	5.05e-06	0.000126	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	4.87e-06	0.000122	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	4.86e-06	0.000121	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	4.8e-06	0.00012	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.77e-06	0.000119	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	4.77e-06	0.000119	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	4.69e-06	0.000117	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.55e-06	0.000114	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.5e-06	0.000112	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	4.43e-06	0.000111	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	4.33e-06	0.000108	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	4.32e-06	0.000108	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—EP300—urinary bladder cancer	4.29e-06	0.000107	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.29e-06	0.000107	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	4.24e-06	0.000106	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	4.14e-06	0.000103	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	4.13e-06	0.000103	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.12e-06	0.000103	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	4.05e-06	0.000101	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	3.94e-06	9.83e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	3.77e-06	9.41e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.37e-06	8.42e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.94e-06	7.34e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.8e-06	7e-05	CbGpPWpGaD
